NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Predictive Factors and Subthalamic Stimulation in Parkinson's Disease
Predictive Factors and Subthalamic Stimulation in Parkinson's Disease

NCT02360683

CompletedN/A

Sponsor: University Hospital, Lille

Conditions: Parkinson's Disease

Interventions: patients with Parkinson's disease

Countries: France

This study identify preoperative predictors of response to subthalamic stimulation at 1 year, 3 years and 5 years in terms of quality of life, from a broad prospective multicenter study French with standardized collection of clinical data , imaging and genetic . The investigators want to identify factors that predict the improvement of quality of life for one year corresponding to a decrease of PDQ39 score of at least 20 %. They believe that improvement would be less likely to become zero to 3 or 5 years and question the indication of the subthalamic stimulation (risks and costs). This is part of a process of "personalization" of the therapeutic care that is of any interest to the subthalamic stimulation. It is a therapeutic option that could be dangerous if patient selection is not optimal , and expensive, if the benefit is not large enough to reduce the number of medications and hospitalizations medium term . In addition, it will quantify the improvement of quality of life in the longer term and harmonize national assessments .

Eligibility overview

Sex: ALL

Age: 18 Years to 75 Years

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria
Inclusion Criteria:

* Patients receiving a pre- therapeutic assessment and therapeutic monitoring for one year , 3 years and 5 years as part of the regular monitoring of the subthalamic stimulation
* Bilateral STN stimulation considered
* Patient able to provide their free and informed consent
* Patient with insurance coverage

Exclusion Criteria:

* Atypical Parkinson's disease do not meet the criteria of stuff .
* MP under 5 years
* Severe cognitive impairment or dementia ( Score Moca \<24 and DSM-IV criteria)
* Parkinson's Psychosis
* Reply to L- dopa \<30 %
* Against indication for surgery
* Severe brain atrophy or abnormal MRI
* The presence of another very serious condition terminal life- short-term prognosis ( malignancy ) is an indication against .
Locations (15)
  • Amiens, France
  • Bron, France
  • Clermont-Ferrand, France
  • Lille, France
  • Marseille, France
  • Nancy, France
  • Nantes, France
  • Nice, France
  • Paris, France
  • Paris, France
  • Poitiers, France
  • Rennes, France
  • Rouen, France
  • Strasbourg, France
  • Toulouse, France